Synthesis, spectroscopic characterization, crystal structure and antifungal
activity of thiourea derivatives containing a thiazole moiety
J = 9.5 Hz, thiazole CH), 6.55(1H, d, J = 9.5 Hz, thiazole
an ethanol-dichloromethane mixture (1:2). A colorless
plate 0.15×0.08×0.005 mm3 was mounted on a glass
fiber in inert oil. Measurements were performed at
100 K on an Oxford Diffraction Xcalibur Nova
CH); 13C NMR (300 MHz, DMSO-d6) in δ (ppm): 179.5
(C=S), 169.1 (C=O),165.0 (C=N), 160.8 (C),141.2 (C),
130.0 (C), 121.4 (C); EI MS, m/z (%): 269( M+,7),
235(10) , 187(8), 142(13), 111(100), 83(4).
diffractometer
with
mirror-focussed
Cu-Kα
radiation to 2 max 152° (99.3% complete to 145°). The
data were corrected for absorption using the multi-scan
method. Of 19592 intensities, 2554 were independent
(Rint 0.051). The structure was refined anisotropically
using SHELXL-97 [32]. NH hydrogens were refined
freely, other H atoms using a riding model. The final
wR2 was 0.081, with a conventional R1 of 0.032, for
2.3.3 N-[(1, 3-thiazol-2-ylamino) carbonothioyl]
morpholine-4-carboxamide (1c)
Elemental analysis for C9H12N4O2S2 (MW=272) in wt %
calc. C=39.70, H= 4.41, N=20.57, S=23.52, found C=
o
39.72, H= 4.45, N=20.56, S= 23.54. m.pt 167-168 C,
yield 90 %. IR (KBr pellet) in cm-1: 3350 (free NH), 3203
(assoc. NH), 1690 (C=O), 1614 (C=N stretching), 1589
189 parameters; S = 1.04; max.
0.27 e Å–3.
1
(aromatic C=C); H NMR (400 MHz, DMSO-d6) in δ
(ppm) and J (Hz) : 12.87 (1H, s, broad, NH), 11.59 (1H,
s, broad, NH), 6.75(1H, d, J = 9.5 Hz, thiazole CH),
6.55(1H, d, J = 9.5 Hz, thiazole CH), 3.7(4H, t, J = 7.6
Hz, morpholine –OCH2), 2.9(4H , t, J = 7.2 Hz,
morpholine –NCH2); 13C NMR (300 MHz, DMSO-d6) in
δ (ppm): 180.3 (C=S), 168.2 (C=O),164.8 (C=N), 162.4
(C),153.5 (C),143.3 (C), 131.2 (C), 123.0 (C); EI MS,
m/z (%): 272( M+,5), 238 (9), 142 (13), 130 (100), 114
(7) , 101(20), 85(23).
2.5 Evaluation of Fungicidal Activity
2.5.1 Broth micro-dilution procedure
Antifungal activity was determined by the broth
micro-dilution procedures and principles of the
Clinical and Laboratory Standards Institute (CLSI)
[33,34]. Minimal inhibitory concentrations for each
compound were investigated against standard
yeast-like fungi, C. albicans (ATCC90028), C. glabrata
(ATCC 32554), C. tropicalis(ATCC 20336). Fungal
colonies of the test organisms were suspended directly
into a small volume of 0.9% saline and further diluted
until turbidity matched the Mc Farland Standard no: 0.5
Petri dishes Sabouraud and Dextrose agar for fungi
were impregnated with these microbial suspensions.
The stock solutions of the synthesized compounds were
prepared in dimethyl sulfoxide (DMSO), which had no
effect on the organisms in the concentrations studied.
The initial concentration was 200 mg mL-1. All of the
dilutions were done with distilled water. The
concentrations of tested compounds were 100, 50, 25,
12.5, 6.25, 3.125 μg mL-1. DMSO was used as negative
control. Nystatin was used as reference drug for
anti-fungal activity. All the inoculated plates were
incubated at 37oC and results were evaluated after
48 h for formation of colonies. The lowest concentration
of the compounds that prevented visible growth
was considered minimal inhibitor concentration (MIC).
2.3.4 N-[ (1, 3 - thiazol -2 - ylamino) carbonothioyl]
butanamide (1d)
Elemental analysis for C8H11N3OS2 (MW=229) in wt %
calc. C=41.92, H= 4.80, N=18.34, S=27.97, found C=
o
41.90, H= 4.83, N=18.31, S= 27.96. m.pt 155- 156 C,
yield 85 %. IR (KBr pellet) in cm-1: 3351 (free NH), 3202
(assoc. NH), 1685 (C=O), 1615 (C=N stretching), 1590
1
(aromatic C=C); H NMR (400 MHz, DMSO-d6) in δ
(ppm) and J (Hz): 12.85 (1H, s, broad, NH), 11.61 (1H,
s, broad, NH), 6.75(1H, d, J = 9.5 Hz, thiazole CH),
6.55(1H, d, J = 9.5 Hz, thiazole CH), 2.48 (2H, t, -CH2, J
= 7.3 Hz), 1.95 (2H, m, -CH2), 0.93 (3H, t, -CH3 ,
J = 7.1 Hz); 13C NMR (300 MHz, DMSO-d6) in δ (ppm):
179.1 (C=S), 168.5 (C=O),164.0 (C=N), 162.4 (C),153.1
(C),140.2 (C), 130.6 (C), 121.4 (C), 25.1, 22.5, 20.0 ; EI
MS, m/z (%): 229( M+,6), 195 (11), 142 (12) , 100 (20)
, 87 (9), 71(100), 44(15).
2.4 X-ray Structure Determination of 1a
Crystal data: C11H8N4O3S2, monoclinic, space group
P21/n, a = 11.7752(6), b= 3.8677(2), c= 27.4126(13) Å,
=92.734(5)°, V = 1247.03 Å3, T = 100K, Z = 4, F (000)
= 632, Dx = 1.642 g cm–3, = 4.0 mm–1. Single crystals
suitable for X-ray diffraction studies were obtained from
552
555